Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cidara Therapeutics, Inc.

Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2022
From Cidara Therapeutics, Inc.
Via GlobeNewswire
Tickers CDTX
Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma
From Cidara Therapeutics, Inc.
Via GlobeNewswire
Tickers CDTX
Cidara Therapeutics Submits NDA for Rezafungin and Announces License Agreement with Melinta Therapeutics for Commercialization of Rezafungin in the U.S.
From Cidara Therapeutics, Inc.
Via GlobeNewswire
Tickers CDTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.